Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.

scientific article published on 7 October 2015

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2015-2335
P698PubMed publication ID26445112

P50authorJens Juul HolstQ28373106
Bolette HartmannQ51055821
Jonatan Ising BaggerQ58110286
Filip K KnopQ59659637
Tina VilsbøllQ60393741
P2093author name stringBirgitte Andersen
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectappetiteQ28578
glucagonQ28163629
P304page(s)4541-4552
P577publication date2015-10-07
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleEffect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
P478volume100

Reverse relations

cites work (P2860)
Q52656812A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects.
Q87841816All in one: Researchers create combination drugs for diabetes and obesity
Q46531147Characterization and quantification of oxyntomodulin in human and rat plasma using high-resolution accurate mass LC-MS.
Q57791608Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme
Q47252691Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults?
Q92709175Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial
Q104064811Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour
Q93000811Gastrointestinal hormones and regulation of gastric emptying
Q38730622Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke
Q37009157Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma
Q47161786Recent advances in understanding/managing type 2 diabetes mellitus
Q30368984Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
Q89230553Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates
Q55234575Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats.
Q60920688The Regulation of Peripheral Metabolism by Gut-Derived Hormones
Q38853094The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers

Search more.